# Phase 5 final source review — Long-horizon health platform

Base: `main`
Branch: `phase-5-health-platform`
Tracking: #81; verification #82; runner #51

## Review conclusion

Phase 5 is **feature-scope complete and source-reviewed** for the final planned Human Health platform layer. It is not release-verified because the final TypeScript/test/build/PWA/browser gates have not executed on an eligible runner/environment.

## Preventive records/reminders

The product does not ship a hidden table of screening, vaccination, laboratory or follow-up schedules. A reminder exists only because the user entered it or recorded guidance received from a clinician/public-health source. Repeat intervals are explicit user data. Due-state logic only compares the entered date with the current date.

## Clinician-friendly export

The clinician discussion summary is generated locally. It separates training history, connected-health observations and user-entered preventive context, and retains source names, units, sample counts and date windows. It carries explicit language that Human Health is not a diagnosis, medication/insulin recommendation, emergency monitor, injury clearance or replacement for source clinical records.

The export is intended to make a conversation easier, not to create a medical chart or claim clinical completeness.

## Capability-model validation

Phase 5 implements a validation registry rather than declaring algorithms validated by fiat. Each model has an intended use, inputs, output, limitations, validation status and evidence list. The `validated-for-intended-use` claim is blocked unless external-study and replication evidence are recorded.

All current built-in models remain `experimental`. Actual external validation requires appropriately designed research and cannot be completed by source code alone.

## Privacy-preserving personal models

The personal-model layer is an on-device deterministic baseline derived from the user's own training/readiness/activity history. It performs no cross-user learning, background network training or automatic sharing. Missing data is not guessed. The snapshot is exportable and descriptive, and its limitations explicitly prohibit diagnosis, dosing, emergency monitoring and injury clearance.

## API/integration platform

Phase 5 defines versioned read scopes (`training:read`, `connected-health:read`, `preventive:read`, `coaching:read`) and builds bundles containing only explicitly selected scopes. File export is local. An optional `window.HumanHealthIntegrationHost` boundary can be supplied by a future reviewed host, but sharing only occurs from an explicit user action after scopes are selected. No third-party provider, credential or background sync target is bundled.

## Regulatory checkpoints

The internal regulatory gate is deliberately conservative:
- medication/insulin dosing and emergency-monitoring profiles are blocked in the current product
- diagnostic claims, patient-specific treatment, clinician decision support, patient-specific risk scores and camera-based clinical assessment require specialist review before implementation/release
- ordinary wellness education remains in normal product/privacy/security/accessibility/evidence review

This gate is an internal escalation mechanism. It does not provide legal advice, regulatory clearance or a medical-device determination.

## Product integrity

Phase 5 does not introduce a universal health score. It preserves the existing separation between fitness capabilities, connected observations, user-entered records, deterministic coaching and future evidence claims.

## UX/PWA review

A dedicated `/platform/` route exposes preventive records/reminders, clinician export, validation status, local personal baseline, scoped integration export and regulatory review controls. The route is included in the service-worker precache and PWA static-check expectations.

## Source-review risks / remaining evidence

1. Final TypeScript/test/build evidence has not run on the eligible runner.
2. Browser persistence/deletion and offline QA remain required.
3. Clinician export should be reviewed with synthetic representative data before release.
4. No current capability model has real external validation evidence recorded; this is intentionally visible.
5. No live third-party integration host is bundled or validated.
6. The regulatory gate is not a substitute for specialist legal/regulatory/clinical review.
7. Production deployment remains a separate approval.

## Merge/deploy gate

Keep the Phase 5 PR draft and unmerged until Cameron explicitly approves merge. Production deployment remains a separate decision.